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Background: Lifestyle and behaviour change are important factors in the prevention of cardiovascular disease and
reduction of premature mortality. Public health initiatives have focused on opportunities for healthcare staff to
deliver lifestyle advice routinely in primary and secondary care but there is no consistent approach to onward
referrals and the rate of uptake of advice remains low. We do not know if advice is more effective in supporting
behaviour change when a systematic approach is taken that includes identification of barriers to change, directing
patients toward services, referral to services, and feedback on outcome.
Methods and design: This is a single-centre, randomized, unblinded feasibility trial in an acute hospital setting
which aims to assess the feasibility of a definitive trial and provide proof of concept for the systematic delivery of
individualized lifestyle advice in patients managed through an acute cardiology in-patient service.
Patients will be recruited before discharge and randomized to two groups. A control group will receive the usual
lifestyle assessment and referral, while an intervention group will receive the usual assessment plus the new
individualized lifestyle assessment and referral. The new assessment will inform assignment of each patient to one
of three categories based on personal barriers to change. Patients may be referred to a formal lifestyle-change
programme, through the ‘Leeds Let’s Change’ website, or they may be guided in self-management, using goal
setting, or they may be assigned to a ‘deferment’ category, for reassessment at follow-up. These latter patients will
be given a contact card for the ‘Leeds Let’s Change’ service.
Discussion: Lifestyle change is an important mechanism for improving health and wellbeing across the population
but there are widely acknowledged difficulties in addressing lifestyle factors with patients and supporting behaviour
change. A systematic approach to assessment would facilitate audit and provide an indicator of the quality of care.
The new assessment template has been designed to be quick and easy to use in practice and could, for example,
be added to a primary care consultation or form part of a nursing discharge assessment in an acute setting.
Trial registration: Current Controlled Trials ISRCTN41781196.
Keywords: Cardiovascular risk factors, Lifestyle change, Randomized controlled trialBackground
Cardiovascular disease is a global killer; it is a major cause
of premature death and morbidity, and is responsible for
over 4 million deaths in Europe annually [1]. It is clear
that promoting good cardiovascular health has numerous
benefits for society, including lower levels of morbidity,* Correspondence: k.m.hill@leeds.ac.uk
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reproduction in any medium, provided the orbetter wellbeing (or quality of life) and lower healthcare
costs. Nevertheless, tackling the lifestyle behaviours asso-
ciated with cardiovascular risk with interventions like
smoking cessation, weight management, alcohol aware-
ness and exercise is complex, as many factors, be they so-
cial and psychological, cultural or economic, may affect
the individual’s willingness and ability to change [2-4].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Health and Clinical Excellence (NICE) [5] states that at-
tempts to change behaviour have been largely unsuc-
cessful and that there is ‘…no strategic approach to
behaviour change across government, the NHS or other
sectors, and many different models, methods and theor-
ies are being used in an uncoordinated way.’ This, NICE
concludes, is despite a mass of evidence from different
disciplines on the theoretical basis for individual and
societal-level behaviours and models of change. Diver-
gent conceptual approaches and heterogeneous research
methods make it difficult to merge evidence to inform
the planning and design of services and their delivery.
Public health initiatives have focused on the oppor-
tunities to deliver lifestyle advice [3]. Healthcare staff in
primary and secondary care routinely discuss lifestyle
with patients but there is no consistent approach to the
referral of patients to receive the support or services re-
quired for change. Moreover, the rate of uptake of life-
style support services remains low [6]. In our previous
work [4,7], we identified five individual barriers to be-
haviour change:
 Low mood, especially anxiety and depression.
 Poor knowledge about healthy lifestyles and poor
education.
 Little support from family and friends.
 Financial and transport difficulties (where cost and
travel is required for attendance at a lifestyle
programme).
 A belief that changing lifestyle will have little impact
on health.
The intervention to be tested will therefore consist of
a new referral assessment for patients. The assessment
will address these barriers to change and will be used to
identify suitable services for patients.Financial incentives
Incentivizing individuals to encourage healthy living was
recently discussed by the National Institute for Health and
Clinical Excellence (NICE) Citizen’s Council [8]. This ap-
proach is already being implemented, for example, the
‘Help 2 Quit’ programme run by Shropshire NHS [9]; the
‘Give It Up For Baby’ run by NHS Tayside [10] offering in-
centives to pregnant women who quit smoking, and an
NHS PCT in the south of England [11] offering financial
incentives for weight loss.
Incentives are becoming more common in public health
interventions for encouraging healthy behaviour, and some
positive results have been reported for increasing weight
loss [12], and levels of physical activity [13]. Nevertheless,
while the use of incentives in this way may be a useful toolin encouraging behaviour change, recent reviews suggest
that further research is needed to justify their widespread
use [14,15]. This study will add to knowledge about
the nature and scale of incentives that people deem
acceptable.
This randomized feasibility trial is being conducted as
part of the vascular research theme: Improving Prevention
of Vascular Events (IMPROVE) in the National Institute
for Health Research Collaboration for Leadership in
Applied Health Research and Care (CLAHRC) for Leeds,
York and Bradford. It will examine feasibility and provide
proof-of-concept evidence for a larger-scale trial to test
the hypothesis that the rate of uptake of lifestyle behaviour
change can be increased by use of a systematic assessment
that tailors the level of lifestyle support offered to individ-
uals according to personal barriers and facilitators to life-
style behaviour change. It is exploratory in nature rather
than a scaled-down, pilot version of the main trial. The de-
sign of the main trial may be modified based on the find-
ings of the feasibility trial.
The intervention (a lifestyle referral assessment) is based
on evidence about key factors that are known to predict
uptake of lifestyle behaviour change [2,4], and is specific-
ally designed for use by care providers at the point where
they might advise patients of lifestyle support services or
refer patients to these support services. It incorporates a
discussion of barriers and facilitators to changing lifestyle
before offering an individualized plan or referral to an ap-
propriate service through Leeds Let’s Change [16], a locally
provided NHS website that provides information on ser-
vices that support lifestyle change. The control action
is the usual healthy-living assessment that has been
implemented in local cardiology services, and which
identifies behaviours and offers brief lifestyle advice
(including a ‘Leeds Let’s Change’ card).Ethical approval
This study was approved by the committee of the National
Research Ethics Service for Yorkshire and the Humber
(Leeds East) on 12 March 2012. REC Reference number:
12/YH/0086.Aims and objectives
The main aim of the study is to assess the feasibility of
conducting a definitive trial in terms of recruitment, use
and acceptability of the intervention, follow-up at 3 and
6 months, and data collection methods. The following
criteria will be used to assess success:
1. Favourable difference shown in referrals and
participation.
2. Favourable changes made through self-management.
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4. Retention rate at 75% or more at 6 months follow-up.
5. Missing data at 10% or less, including 6 months
follow-up.
6. Included participants are representative of the target
population.
In addition, the study aims to establish suitable pro-
cedures for delivering the intervention and conducting
assessments and procedures for ensuring recruitment
and retention in the study. Finally, the study aims to
discover whether using a structured, individualized ap-
proach to lifestyle assessment and referral will improve
uptake and participation in lifestyle- and behaviour-
change interventions;
The study will also examine, qualitatively, the acceptabil-
ity of the assessment tool to patients in an acute cardi-
ology setting as well as patients’ experiences of making
lifestyle changes in order to develop effective recruitment
and retention strategies.
The study will have a number of quantitative objectives:
1. To determine how many patients accept referral to a
formal lifestyle programme;
2. To determine how many patients participate in a
lifestyle-change intervention or initiate self-managed
change;
3. To investigate the uptake of lifestyle intervention in
relation to subsequent behaviour change and impact
on health-related quality of life, mood and social
satisfaction;
4. To estimate feasible eligibility, recruitment and
refusal rates, and 3- and 6-months follow-up rates;
5. To measure key outcome domains (that is, for
completion rates, missing data, estimates, variances
and 95% confidence intervals for the difference
between the control and intervention groups)
for patients including clinical indicators and
patient-reported measures of social satisfaction;
health-related quality of life; and mood;
6. To synthesize data to inform the sample size of a
definitive trial;
7. To determine the acceptability (and factors
influencing this) of financial incentives as a method
to encourage behaviour change, their pricing and
factors influencing this.Methods and design
This study is being conducted in cardiology wards at
the Leeds Teaching Hospitals Trust with patients admit-
ted to hospital, who are subsequently referred to the
cardiac rehabilitation team or discharged with no con-
firmed diagnosis of cardiac event.Trial design
The study is designed as a single-centre, randomized,
unblinded feasibility trial in an acute hospital setting
(Figure 1).
Incentives sub-study
A sub-study will explore the acceptability and potential use-
fulness of using financial incentives to help patients over-
come motivational and financial barriers to changing their
health behaviour. Incentives will not be offered within the
trial but we will explore theoretical aspects, such as the pri-
cing and type of incentives offered, and the association of
type and magnitude of incentive with perceived difficulty of
change. A survey questionnaire specifically designed to ex-
plore attitudes to incentives will form part of the study
assessments.
Study conditions
Participants are randomized, using block randomization
with randomly varying block sizes, in equal proportions,
with no stratification, to receive either usual lifestyle assess-
ment or an enhanced lifestyle assessment using an auto-
mated 24-hour telephone randomization service provided
by the clinical trials research unit. The usual lifestyle as-
sessment comprises a series of questions that identify life-
style factors (that is, smoking habits, alcohol consumption,
physical activity and weight) that contribute to an in-
creased risk of vascular events. The enhanced lifestyle as-
sessment includes the usual assessment but also contains
an evidence-based lifestyle referral assessment based on
factors that predict change [2,4]. The aim of this enhanced
assessment is to aid healthcare professionals in directing
patients toward appropriate lifestyle-change interventions.
The assessments are delivered in the hospital ward by re-
search staff before discharge.
Eligibility criteria
Men or women aged between 40 and 74 years of age at the
time of screening, who are willing and able to give written
informed consent, and have been admitted to hospital with
a diagnosis of acute coronary event, myocardial infarction
or symptoms of a cardiac nature will be eligible for inclu-
sion in the study.
Patients who are currently receiving specialist treatment
with a primary focus on alcohol, smoking, diet or exercise,
or who have no modifiable risk factors for vascular events
will be excluded from the study. In addition, patients who
will be unavailable for follow-up because they have no fixed
abode, are mainly resident abroad, or are currently serving
a sentence in prison or have outstanding legal issues likely
to lead to imprisonment will be excluded, as will patients
who are unable to take part in either intervention using
spoken English or are unable to complete the English-
language outcome measure tools without assistance.
Questionnaires 
at 3 months
Hospital staff or the researcher  
explains the study
Patient consents to  
take part 
YES
Receive new 
lifestyle assessment
Randomisation to 
either group
Receive usual 
lifestyle assessment
Questionnaires 
at 6 months
END OF STUDY
NO Normal medical 
care
Normal medical 
care
Figure 1 Trial design summary.
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Based on figures available at the planning stage, we can
estimate that cardiology services in the Leeds Teaching
Hospitals Trust receive around 800 admissions per month;
on average approximately 300 of these admissions are
people who have had an acute myocardial infarction and
150 are people who have experienced an acute cardiac
event; the remainder are elective admissions for cardiac-
related procedures such as stenting. It is therefore esti-
mated that ten patients per week could take part in the
study. This estimate is also based on local knowledge and
previous experience of recruiting patients with acute
stroke in a similar setting [17].
Recruitment strategy
All patients admitted to the selected wards are consid-
ered potential participants. Potentially eligible patients
are identified by research staff from the ward admissionsregister or by direct referral from ward staff. These pa-
tients are approached by the research team or ward staff
to determine willingness to participate and an eligibility
checklist is completed. Assessment of psychological status
and cognitive capacity to participate is made in consult-
ation with ward staff. All patients meeting the eligibility
criteria are provided with an explanation of the study and
a patient information sheet, and have an opportunity to
ask questions. If willing to continue, they are invited to
participate in the study and give written consent. Partici-
pation in the study does not alter their usual care. Reasons
for nonparticipation, date of birth, sex and postcode are
recorded whenever possible.Recruitment rates, exclusions and generalizability
The rates of recruitment to the trial are given in Figure 2.
Figure 3 provides the numbers of participants at each
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Figure 2 Recruitment: predicted, weekly and cumulative accrual rates. Cum, cumulative; Exp, expected.
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Table 1.
Study measures
Visit schedule This is a longitudinal study with two
follow-up points. Data (Table 2) are collected at baseline
(during the hospital admission), then at three and six
months following randomization, plus or minus two weeks.
Follow-up data are collected by email, post and telephone,Assessed for Eli
All patients admitted to t
wards in Leeds G
Randomised (n
New Assessment (n=66)
Received as intended (59)
Enrolment
Allocation
Usual Assessm
Received (13
Figure 3 Passage of participants through trial.or during a home visit if required. Recommended tech-
niques, such as enclosing stamped, addressed envelopes for
returning questionnaires and sending reminders, will be
used to maximize response rates [18].
Assessment tools Change in lifestyle will be determined
by self-reported changes in alcohol consumption [19],
smoking, diet and physical activity. Social satisfaction will
be measured using the Social Satisfaction Questionnaire, agibility (n=887)
he selected cardiology 
eneral Infirmary
=132)
Excluded (n=755, 85%)
Aged <40 or >74 years (376)
Unable to participate (229)
Discharged before approached (166)
Not English speaking (24)
Too unwell to approach (22) 
Cognitively impaired (16)
Unavailable for follow-up (1)
Unwilling to give written informed consent (72)
No risk factors for vascular events (52)
No diagnosis or symptoms of a cardiac nature (21)
Already receiving specialist treatment (3)
In prison or with outstanding legal issues (1)
Of no fixed abode (1)
No New Assessment (n=66)
Not received as intended (66)
ent
0)
Table 1 Patient characteristics in the screened and
randomized samples
Screened (n = 887) Randomized (n = 132)
Age (years)
Up to 35 32 (3.6) 0 (0.0)
35 to 40 13 (1.5) 0 (0.0)
40 to 50 82 (9.3) 25 (18.9)
50 to 60 149 (16.9) 44 (33.3)
60 to 70 163 (18.5) 44 (33.3)
70 to 75 107 (12.1) 19 (14.4)
75 to 80 130 (14.7) 0 (0.0)
80 to 85 122 (13.8) 0 (0.0)
85 and over 85 (9.6) 0 (0.0)
Male 467 (52.6) 81 (61.4)
Female 420 (47.4) 51 (38.6)
Reasons for admission
Symptoms 718 (81.0) 116 (87.9)
Acute coronary event 97 (10.9) 15 (11.4)
Elective procedure 26 (2.9) 0 (0.0)
Atrial fibrillation 10 (1.1) 1 (0.8)
Other 6 (0.7) 0 (0.0)
Unknown 30 (3.4) 0 (0.0)
Data are n (%). Age is available for 883 screened patients.
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measure in people with substance use disorders [20]. Sub-
jective wellbeing, psychological problems and functioning
will be measured using the Clinical Outcomes in Routine
Evaluation (10-item version). [21]. Health-related quality
of life will be assessed using the European Quality of Life -
5 Dimensions (EQ-5D) [22]. The EQ-5D is a generic
measure of health status, where health is characterized on
five dimensions (mobility, self-care, ability to undertake
usual activities, pain, anxiety or depression). The EQ-5D
visual analogue scale will also be completed. The EQ-5D
has been validated in the UK.
Health economics
Patients will also complete a questionnaire developed
specifically for the trial as part of the incentives sub-
study. The Valuing Health Change Questionnaire asks
about the perceived difficulty in changing health behav-
iour, willingness to accept financial (dis)incentives (and
minimum acceptable incentive amounts) and some sup-
plementary questions required for the analysis in order
to analyze the incentive, including attitudinal and time
preference questions.
Qualitative data
There are no suitable quantitative measures of uptake,
participation and maintenance of behaviour change.Information about participants’ acceptance of lifestyle ad-
vice, motivation to change and experience of effecting
change will therefore be collected using qualitative methods
in a structured interview, which will be conducted at the
three and six-month follow-up points. Interviews will be
conducted face-to-face or by telephone. The primary end-
points for the trial will be coded from this information and
analyzed quantitatively. The interview data will be analyzed
using a thematic framework approach and will be used to
inform the development of a larger-scale trial.
Sample size calculations
We planned to recruit a minimum of 120 patients over four
months, randomized equally between intervention and con-
trol groups. Assuming that loss to follow-up will be no
greater than 25% at 6 months, this will leave 90 patients for
our study. This study is designed to assess the feasibility of
conducting a definitive trial; because effectiveness is not be-
ing evaluated, a formal power calculation would not usually
be considered necessary for the primary objectives. How-
ever, there is a secondary proof-of-concept element to the
study. Based on a two-sample Student’s t test with a 2-sided
5% significance level, there would be an 80% power of
detecting a standardized effect size of 0.6 in any outcome
variable with 90 patients at analysis. As this is larger than
the clinically meaningful effect of 0.4, our results will be
classed as inconclusive rather than negative if no statisti-
cally significant difference is found. We will report 95%
confidence intervals and interpret the level of uncertainty
based on these.
Statistical analysis
The primary analysis will be conducted on the intention-
to-treat sample, including all randomized participants in
the groups to which they were randomized. Analysis will
focus on descriptive statistics and confidence interval esti-
mation rather than formal hypothesis testing. The primary
outcome of successful uptake of lifestyle advice is made up
of two components: accepting referral or self-referral and
participation in lifestyle interventions or self-management.
The first is a binary outcome (yes, no) while the second is
ordinal (none, initiated, persisted and maintained). Both
will be summarized in each group, along with 95% confi-
dence intervals to provide evidence of proof of concept.
A standard CONSORT-approved diagram will depict the
flow of patients through the study from screening to ana-
lysis (see Figure 3 for enrolment to allocation stages only).
This diagram summarizes the feasible eligible, recruitment
and refusal rates. It will also summarize the 3- and 6-
month follow-up rates. The distributions of the data at
baseline, and at 3 and 6 months after randomization will
be explored, with unusual values noted and explained.
Baseline variables will be summarized as n (%), mean
(standard deviation) or median (interquartile range), as
Table 2 Data collection schedule
Variable Measurement tool Time-point Type of
administrationScreening Baseline 3 months 6 months
Age Demographics × Audit
Sex Demographics × Audit
Postcode Demographics × Audit
Health-related quality of life EQ-5D × × × Posted questionnaire
Mood Clinical Outcomes in Routine
Evaluation (10-item version)
× × × Posted questionnaire
Satisfaction Social Satisfaction Questionnaire × × × Posted questionnaire
Costs Valuing Health Change Questionnaire × × × Posted questionnaire
Uptake Qualitative × × Interview
Adherence Qualitative × × Interview
Smoking status Qualitative × × × Interview
Alcohol consumption Qualitative × × × Interview
Diet Qualitative × × × Interview
Physical activity Qualitative × × × Interview
EQ-5D, European Quality of Life - 5 Dimensions.
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characterize the sample and look for any imbalances.
Risk factors for vascular events will be summarized, to-
gether with the frequency at which patients seek help.
Referral choice will then be summarized by randomized
group. Responses to the new assessment will be ex-
plored, including any changes between first and second
assessments. Protocol violations will be reported, in-
cluding an exploration of the predictors of any missing
data. The primary outcomes will be summarized de-
scriptively by behaviour change in relation to risk fac-
tors and by health-related quality of life, mood and
social satisfaction to assess the relationship between the
process and the clinical endpoints. Completion rates
and missing item data will be summarized for key sec-
ondary outcomes, together with estimates and variances
to aid calculation of sample size for a definitive trial.Patient and public involvement (PPI) group
Development of the protocol and patient materials (in-
formation sheets and consent forms) benefitted greatly
from the involvement of the CLAHRC vascular theme
patient and public involvement (PPI) group. The group
comprises people with a range of experience of vascular
and chronic respiratory conditions, either as patients or
as carers. The outcome of the consultation with the PPI
group was summarized in an appendix to the full trial
protocol (available on request) and submitted to the
local research ethics committee. We will undertake fur-
ther consultation with a wider group of service usersduring the later phase of the trial, specifically, at the dis-
semination stage.
Discussion
Reducing demands on the NHS by giving advice and in-
formation to people to enable them to manage and
maintain their own health was one of the tenets of the
Wanless report [23]. This has been enacted by NHS
Trusts across the United Kingdom through the ‘Making
Every Contact Count’ initiative by focusing on staff edu-
cation and training [24]. Less emphasis has been placed
on the type of advice, and its outcome in terms of refer-
ral to formal interventions, but evidence suggests that
lifestyle advice alone has limited success. The assess-
ment of lifestyle is not standardized, although some
tools exist and are used in clinical practice. We took
evidence from literature reviews and qualitative studies
conducted as part of the CLAHRC IMPROVE project
and designed a short and simple, systematic assessment
that takes into account the barriers and facilitators ex-
perienced by patients trying to change their lifestyle
[2,4]. We hypothesized that a more individualized ap-
proach to assessing lifestyle had the potential to improve
uptake and participation in formal lifestyle- or behaviour-
change programmes, or improve self-management, to
achieve healthy behaviour.
If the results of this preliminary work are positive, and
our success criteria are met, we intend to develop a large-
scale trial to evaluate the clinical and cost effectiveness of
systematized lifestyle assessment on reducing risk factors
for cardiovascular disease and improving health status.
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emotional wellbeing, would be considered secondary out-
comes. This study is designed to demonstrate that such a
trial could be implemented in an acute cardiac setting and
to develop an optimized, practicable protocol; secondly, to
show that the assessment is viable and can be implemented
with patients; and thirdly, to provide an estimate, and a
confidence interval, for the efficacy of the assessment, to
determine whether a definitive, large-scale trial would
be warranted. These aims constitute a balance between, on
the one hand, feasibility work and, on the other, proof
of concept.
This is the first study of this type of intervention, to our
knowledge, in an acute hospital setting, and the first in car-
diology. This study paves the way for a larger-scale trial by
giving us insight into operational procedures, such as re-
cruitment and follow-up of patients; and the assumptions
necessary to calculate the required sample sizes. It also al-
lows us to test and refine methods of data collection and
intervention provision. Our larger-scale trial would be
multicentre and would require us to consider training hos-
pital staff to deliver the assessment on the ward, as well as
introduce different methods of directing patients toward lo-
cally available formal programmes. This preliminary work
provides a case-study for wider roll-out and generalization
and will give a useful indication as to whether there is
benefit in approaching different lifestyle behaviours in dif-
ferent ways.
Given current emphasis on lifestyle change as a mechan-
ism for improving health and wellbeing across the popula-
tion, the significance of the larger-scale trial to which this
would lead is important. The difficulties of addressing life-
style factors and supporting behaviour change are widely
acknowledged; therefore, we consider that the results from
this study will be of value both to the acute setting and to
primary care. A systematic approach to assessment would
facilitate audit and provide an indicator of the quality of
care. It would also facilitate feedback to clinical commis-
sioners and enable service improvement measures to be
implemented where required. The new assessment tem-
plate has been designed to be quick and easy to use in
practice and could, for example, be added to a primary care
consultation or form part of a nursing discharge assess-
ment in an acute setting.
Trial status
The trial is on-going.
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